IP Library Granted Patent US 6,965,020
Granted Patent B2
US 6,965,020 · App. 09/952,387 · Granted Nov 15, 2005

Nucleic acid labeling compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,965,020
App. No.
09/952,387
Granted
Nov 15, 2005
Kind
B2
Abstract

Nucleic acid labeling compounds containing heterocyclic derivatives are disclosed. The heterocyclic derivative containing compounds are synthesized by condensing a heterocyclic derivative with a cyclic group (e.g. a ribofuranose derivative). The labeling compounds are suitable for enzymatic attachment to a nucleic acid, either terminally or internally, to provide a mechanism of nucleic acid detection.

Claims (20)

1. A nucleic acid labeling compound of the following structure:

wherein A is a functional group that permits the attachment of the nucleic acid labeling compound to a nucleic acid;

X is O, S, NR 1 or CHR 2 , wherein R 1 and R 2 are, independently, H, alkyl or aryl;

Y is H, N 3 , F, OR 9 , SR 9 or NHR 9 , wherein R 9 is H, alkyl or aryl;

Z is H, N 3 , F or OR 10 , wherein R 10 is H, alkyl or aryl;

L is a linker moeity;

Q is a detectable moiety; and

M is a connecting group, wherein m is an integer ranging from 0 to about 3.

2. A nucleic acid labeling compound according to claim 1 , wherein A is H 4 O 9 P 3 —; X is O; Y is H or OR 9 , wherein R 9 is H, alkyl or aryl; Z is H, N 3 , F or OR 10 , wherein R 10 is H, alkyl or aryl; L is amido alkyl; Q is biotin or a fluorescein; wherein m is 0, 1, or2.

3. A nucleic acid labeling compound according to claim 1 , wherein A is H 4 O 9 P 3 —; X is O; Y is H or OR 9 , wherein R 9 is H, alkyl or aryl; Z is H, N 3 , F or OR 10 wherein R 10 is H, alkyl or aryl; L is —C(O)NH(CH 2 ) n NH—, wherein n is an integer ranging from about 2 to about 10; Q is biotin or a fluorescein; wherein m is 0, 1, or 2.

4. A nucleic acid labeling compound according to claim 1 , wherein Y is H or OH; Z is H or OH; L is —C(O)NH(CH 2 ) 4 NH—; and Q is biotin or a carboxyfluorescein.

5. A nucleic acid labeling compound according to claim 1 , wherein Y is OH; Z is H; L is —C(O)NH(CH 2 ) 4 NH—; m is 0; Q is biotin.

6. A nucleic acid labeling compound according to claim 1 , wherein Y is OH; Z is H; L is —C(O)NH(CH 2 ) 4 NH—; m is 0; and Q is a carboxyfluorescein.

7. A nucleic acid labeling compound according to claim 1 , having the structure:

8. A nucleic acid labeling compound according to claim 1 , having the structure:

9. A nucleic acid labeling compound according to claim 3 , wherein Y is H or OH; Z is H or OH; L is —C(O)NH(CH 2 ) 2 NH—; and Q is biotin or a carboxyfluorescein.

10. A nucleic acid labeling compound according to claim 9 , wherein Y is OH; Z is H; L is —C(O)NH(CH 2 ) 2 NH—; and Q is biotin.

11. A nucleic acid labeling compound according to claim 9 , wherein Y is OH; Z is H; and M is —C(O)(CH 2 ) 5 NH—.

12. A nucleic acid derivative produced by coupling a nucleic acid labeling compound according to claim 4 with a nucleic acid.

13. A method of synthesizing a labeled nucleic acid comprising attaching a nucleic acid labeling compound according to claim 3 to a nucleic acid.

Assignments (4)
NOTICE OF RELEASE Recorded Apr 5, 2016
From: BANK OF AMERICA, N.A.
To: AFFYMETRIX, INC.
Reel/Frame 038361/0891 →
RELEASE OF SECURITY INTEREST Recorded Nov 13, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: AFFYMETRIX, INC.
Reel/Frame 037109/0132 →
SECURITY INTEREST Recorded Oct 28, 2015
From: AFFYMETRIX, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036988/0166 →
SECURITY AGREEMENT Recorded Jun 27, 2012
From: AFFYMETRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028465/0541 →